The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Open accessAbstract
Recombinant adeno-associated viral (AAV) vectors have rapidly advanced to the forefront of gene therapy in the past decade. The exponential progress of AAV-based vectors has been made possible by the isolation of several naturally occurring AAV serotypes and over 100 AAV variants from different animal species. These isolates are ideally suited to development into human gene therapy vectors due to their diverse tissue tropisms and potential to evade preexisting neutralizing antibodies against the common human AAV serotype 2. Despite their prolific application in several animal models of disease, the mechanisms underlying selective tropisms of AAV serotypes remain largely unknown. Efforts to understand cell surface receptor usage and intracellular trafficking pathways exploited by AAV continue to provide significant insight into the biology of AAV vectors. Such unique traits are thought to arise from differences in surface topology of the capsids of AAV serotypes and variants. In addition to the aforementioned naturally evolved AAV isolates, several strategies to engineer hybrid AAV serotype vectors have been formulated in recent years. The generation of mosaic or chimeric vectors through the transcapsidation or marker-rescue/domain-swapping approach, respectively, is notable in this regard. More recently, combinatorial strategies for engineering AAV vectors using error-prone PCR, DNA shuffling, and other molecular cloning techniques have been established. The latter library-based approaches can serve as powerful tools in the generation of low-immunogenic and cell/tissue type-specific AAV vectors for gene delivery. This review is focused on recent developments in the isolation of novel AAV serotypes and isolates, their production and purification, diverse tissue tropisms, mechanisms of cellular entry/trafficking, and capsid structure. Strategies for engineering hybrid AAV vectors derived from AAV serotypes and potential implications of the rapidly expanding AAV vector toolkit are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Self-citationXiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Self-citationZolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Self-citationClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
DNA shuffling of a family of genes from diverse species accelerates directed evolution
Crameri, A., Raillard, S.-A., Bermudez, E., & Stemmer, W. P. C. (1998) · Nature · doi:10.1038/34663 · Cited by 825
Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus
Seisenberger, G., Ried, M. U., Endreß, T., Büning, H., Hallek, M., & Bräuchle, C. (2001) · Science · doi:10.1126/science.1064103 · Cited by 820
Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Self-citationBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735
Self-citationαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Self-citationNovel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 608
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Phillipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 565
McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547
Self-citationGene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538 · cited 1×
“have extended the error-prone PCR and DNA-shuffling strategy into the realm of AAV vectors by using a single AAV2 capsid gene and random mutations as a source of diversity to select for variants that can escape neutralizing antibodies [121,122].”
BackgroundHoggan, M. D., Blacklow, N. R., & Rowe, W. P. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1467 · Cited by 536
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532 · cited 1×
“Following receptor binding, AAV2 particles are endocytosed into the cell via clathrin-coated pits [86].”
BackgroundSelf-citationDavidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
New recombinant serotypes of AAV vectors
Gao, G., Vandenberghe, L., & Wilson, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054065057 · Cited by 487
Samulski, R. J., Berns, K. I., Tan, M., & Muzyczka, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2077 · Cited by 466
Self-citationInsect Cells as a Factory to Produce Adeno-Associated Virus Type 2 Vectors
Urabe, M., Ding, C., & Kotin, R. M. (2002) · Human Gene Therapy · doi:10.1089/10430340260355347 · Cited by 457
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., & Chiorini, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6884-6893.2001 · Cited by 427
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380
Wang, Z., Ma, H.-I., Li, J., Sun, L., Zhang, J., & Xiao, X. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302133 · Cited by 367
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
Self-citationOpie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
Identification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355
Girod, A., Wobus, C. E., Zádori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., & Hallek, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-973 · Cited by 354
Grimm, D., & Kay, M. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 350
Grimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344 · cited 1×
“Most studies to date have adopted a bcross-packagingQ strategy to generate pseudotyped AAV vectors based on the discovery that expression of AAV2 Rep proteins together with capsid proteins of a different serotype results in formation of viral particles that package AAV2 vector genomes [47,48].”
BackgroundUpdate on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
Erles, K., Seb�kov�, P., & Schlehofer, J. R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199911)59:3<406::aid-jmv22>3.0.co;2-n · Cited by 342
Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice
Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S.-I., Nara, Y., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.214-224.2005 · Cited by 327
Halbert, C. L., Allen, J. M., & Miller, A. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6615-6624.2001 · Cited by 314
Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.-P., & Wilson, J. M. (2001) · Human Gene Therapy · doi:10.1089/104303401450988 · Cited by 297
Douar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., & Engelhardt, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9184-9196.2000 · Cited by 269
Halbert, C. L., Rutledge, E. A., Allen, J. M., Russell, D. W., & Miller, A. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1524-1532.2000 · Cited by 259
Intracellular trafficking of adeno-associated viral vectors
Ding, W., Zhang, L., Yan, Z., & Engelhardt, J. F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302527 · Cited by 251
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
Blankinship, M. J., Gregorevic, P., Allen, J. M., Harper, S. Q., Harper, H., Halbert, C. L., Miller, D. A., & Chamberlain, J. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.016 · Cited by 251
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246 · cited 1×
“Subsequent interactions with human fibroblast growth factor receptor 1 (FGFR1) [73], hepatocyte growth factor receptor [74], and integrins aVh5/a5h1 ([75], A.”
BackgroundMori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 245
Adeno-associated virus 2 co-receptors?-first reply
Qing, K., Hansen, J., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/8526 · Cited by 228
Yan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222
Peden, C. S., Burger, C., Muzyczka, N., & Mandel, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6344-6359.2004 · Cited by 222
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J., Surosky, R., Lochrie, M., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0495 · Cited by 208
Adeno-Associated Virus Vectors in Clinical Trials
Carter, B. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.541 · Cited by 206
Yang, G. S., Schmidt, M., Yan, Z., Lindbloom, J. D., Harding, T. C., Donahue, B. A., Engelhardt, J. F., Kotin, R., & Davidson, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7651-7660.2002 · Cited by 204
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Bleker, S., Sonntag, F., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2528-2540.2005 · Cited by 200 · cited 1×
“For example, the acidic pH of the endosomal lumen is likely to induce conformational changes of key capsid subunits necessary for priming the virus for successful endosomal release or other downstream events [92].”
BackgroundLaboratory-Directed Protein Evolution
Yuan, L., Kurek, I., English, J., & Keenan, R. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.3.373-392.2005 · Cited by 198
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus
Georg-Fries, B., Biederlack, S., Wolf, J., & Zur Hausen, H. (1984) · Virology · doi:10.1016/0042-6822(84)90272-1 · Cited by 195
AAV hybrid serotypes: improved vectors for gene delivery
Choi, V., McCarty, D., & Samulski, R. (2005) · Current Gene Therapy · doi:10.2174/1566523054064968 · Cited by 191
Self-citationCharacterization of the DNA of a defective human parvovirus isolated from a genital site
Bantel-Schaal, U., & Zur Hausen, H. (1984) · Virology · doi:10.1016/0042-6822(84)90271-x · Cited by 188
Lux, K., Goerlitz, N., Schlemminger, S., Perabò, L., Goldnau, D., Endell, J., Leike, K., Kofler, D. M., Finke, S., Hallek, M. J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11776-11787.2005 · Cited by 186
Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection
Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10371-10376.1999 · Cited by 186
Fu, H., Muenzer, J., Samulski, R. J., Breese, G., Sifford, J., Zeng, X., & McCarty, D. M. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.021 · Cited by 181
Self-citationRabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., & Samulski, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4421-4432.2004 · Cited by 171
Self-citationAdenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W. S., Warrington, K. H., Hearing, P., Hughes, J. A., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 171
Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography
Kaludov, N., Handelman, B., & Chiorini, J. A. (2002) · Human Gene Therapy · doi:10.1089/104303402320139014 · Cited by 167
Serologic Evidence for Human Infection With Adenovirus-Associated Viruses
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/40.2.319 · Cited by 166
Generation and characterization of chimeric recombinant AAV vectors
Hauck, B., Chen, L., & Xiao, W. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00012-1 · Cited by 160
Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain
Wang, C., Wang, C.-M., Clark, K. R., & Sferra, T. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302011 · Cited by 158
Hansen, J. J., Qing, K., Kwon, H., Mah, C. S., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 158
Conway, J. E., Rhys, C. A., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G. S., & Byrne, B. J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300937 · Cited by 158
Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., & Brown, K. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-8-2077 · Cited by 148
Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System
Kohlbrenner, E., Aslanidi, G., Nash, K. R., Shklyaev, S., Campbell‐Thompson, M., Byrne, B. J., Snyder, R. O., Muzyczka, N., Warrington, K. H., & Zolotukhin, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.018 · Cited by 147
Bantel‐Schaal, U., Hub, B., & Kartenbeck, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2340-2349.2002 · Cited by 144
Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors
Alisky, J. M., Hughes, S. M., Sauter, S. L., Jolly, D. J., Dubensky, T. W., Staber, P. D., Chiorini, J. A., & Davidson, B. L. (2000) · Neuroreport · doi:10.1097/00001756-200008210-00013 · Cited by 142
Comparison of Adenoviral and Adeno-Associated Viral Vectors for Pancreatic Gene Delivery In Vivo
Wang, A. Y., Peng, P. D., Ehrhardt, A., Storm, T. A., & Kay, M. A. (2004) · Human Gene Therapy · doi:10.1089/104303404322959551 · Cited by 141
Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus
Rabinowitz, J. E., Xiao, W., & Samulski, R. J. (1999) · Virology · doi:10.1006/viro.1999.0045 · Cited by 136 · cited 1×
“Other reports [113,114] have also shown that mosaic AAV generated from two noninfectious AAV2 mutants can regain infectivity when prepared using optimal plasmid ratios.”
BackgroundSelf-citationCombinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virus
Perabo, L., Endell, J., King, S., Lux, K., Goldnau, D., Hallek, M., & Büning, H. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.849 · Cited by 136
Davidoff, A. M., Ng, C. Y., Sleep, S., Gray, J. T., Azam, S. A., Zhao, Y., McIntosh, J., Karimipoor, M., & Nathwani, A. C. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.07.001 · Cited by 135
Hansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4080-4090.2001 · Cited by 129 · cited 1×
“Further analysis revealed impaired trafficking to the nucleus as a major limiting step for AAV2 transduction in NIH3T3 cells [84,85].”
BackgroundCharacterization of Tissue Tropism Determinants of Adeno-Associated Virus Type 1
Hauck, B., & Xiao, W. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2768-2774.2003 · Cited by 124
AAV transcytosis through barrier epithelia and endothelium
Di Pasquale, G., & Chiorini, J. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.007 · Cited by 121
Grimm, D., Pandey, K., Nakai, H., Storm, T. A., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.426-439.2006 · Cited by 118
Scalable Generation of High-Titer Recombinant Adeno-Associated Virus Type 5 in Insect Cells
Urabe, M., Nakakura, T., Xin, K.-Q., Obara, Y., Mizukami, H., Kume, A., Kotin, R. M., & Ozawa, K. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1874-1885.2006 · Cited by 117
rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion
Ding, W., Zhang, L. N., Yeaman, C. A., & Engelhardt, J. F. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.002 · Cited by 116
Structure of Adeno-Associated Virus Type 4
Padron, E., Bowman, V. D., Kaludov, N. K., Govindasamy, L., Levy, H. C., Nick, P., McKENNA, R. V., Muzyczka, N., Chiorini, J. A., Baker, T. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5047-5058.2005 · Cited by 116
Structure of Adeno-Associated Virus Serotype 5
Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., & Zabner, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3361-3371.2004 · Cited by 114
Chen, S., Kapturczak, M., Loiler, S., Zolotukhin, S., Glushakova, O. Y., Madsen, K., Samulski, R. J., Hauswirth, W. W., Campbell‐Thompson, M., Berns, K. I., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.235 · Cited by 112
Self-citationAdeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry
Seiler, M. P., Miller, A. D., Zabner, J., & Halbert, C. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.10 · Cited by 104
Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles
Bossis, I., & Chiorini, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6799-6810.2003 · Cited by 103
Infection of Purified Nuclei by Adeno-associated Virus 2
Hansen, J. J., Qing, K., & Srivastava, A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0457 · Cited by 102
Soong, N.-W., Nomura, L. E., Pekrun, K., Reed, M., Sheppard, L., Dawes, G. N., & Stemmer, W. P. C. (2000) · Nature Genetics · doi:10.1038/78132 · Cited by 101
A Single-Step Affinity Column for Purification of Serotype-5 Based Adeno-associated Viral Vectors
Auricchio, A., O'Connor, E., Hildinger, M., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0462 · Cited by 96
Brument, N., Morenweiser, R., Blouin, V., Toublanc, E., Raimbaud, I., Cherel, Y., Folliot, S., Gaden, F., Boulanger, P. A., KRONERLUX, G., et al. (2002) · Molecular Therapy · doi:10.1016/s1525-0016(02)90719-7 · Cited by 91
Custom Adeno-Associated Virus Capsids: The Next Generation of Recombinant Vectors with Novel Tropism
Muzyczka, N., & Warrington, K. H. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.408 · Cited by 89
Xu, D., McCarty, D. M., Fernandes, A., Fisher, M. H., Samulski, R. J., & Juliano, R. L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.019 · Cited by 88
Self-citationChadeuf, G., Favre, D., Tessier, J., Provost, N., Nony, P., Kleinschmidt, J., Moullier, P., & Salvetti, A. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200007/08)2:4<260::aid-jgm111>3.0.co;2-8 · Cited by 88
Arnold, G. S., Sasser, A. K., Stachler, M. D., & Bartlett, J. S. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.014 · Cited by 88
Seroepidemiological and Ecological Studies of the Adenovirus-Associated Satellite Viruses
Parks, W. P., Boucher, D. W., Melnick, J. L., Taber, L. H., & Yow, M. D. (1970) · Infection and Immunity · doi:10.1128/iai.2.6.716-722.1970 · Cited by 86
Cloning and Characterization of a Bovine Adeno-Associated Virus
Schmidt, M., Katano, H., Bossis, I., & Chiorini, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6509-6516.2004 · Cited by 84
Breeding of retroviruses by DNA shuffling for improved stability and processing yields
Powell, S. K., Kaloss, M., Pinkstaff, A., McKee, R. C., Burimski, I., Pensiero, M. N., Otto, E., Stemmer, W. P. C., & Soong, N.-W. (2000) · Nature Biotechnology · doi:10.1038/82391 · Cited by 83
Meghrous, J., Aucoin, M. G., Jacob, D., Chahal, P. S., Arcand, N., & Kamen, A. (2005) · Biotechnology Progress · doi:10.1021/bp049802e · Cited by 83
Altering AAV tropism with mosaic viral capsids
Gigout, L. I., Rebollo, P., Clement, N., Warrington, K. H., Muzyczka, N., Linden, R. M., & Weber, T. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.005 · Cited by 79
Liu, X., Voulgaropoulou, F., Chen, R., Johnson, P. R., & Clark, K. R. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0132 · Cited by 79
Bowles, D. E., Rabinowitz, J. E., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.423-432.2003 · Cited by 76
Self-citationSerum-free production and column purification of adeno-associated virus type 5
Smith, R. H., Ding, C., & Kotin, R. M. (2003) · Journal of Virological Methods · doi:10.1016/j.jviromet.2003.09.002 · Cited by 74
A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus
Farkas, S. L., Zádori, Z., Benkő, M., Essbauer, S. S., Harrach, B., & Tijssen, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.19616-0 · Cited by 74
Rep/Cap Gene Amplification and High-Yield Production of AAV in an A549 Cell Line Expressing Rep/Cap
Gao, G., Lu, F., Sanmiguel, J. C., Tran, P. T., Abbas, Z., Lynd, K. S., Marsh, J. W., Spinner, N. B., & Wilson, J. M. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0591 · Cited by 73
Ding, W., Yan, Z., Žák, R., Saavedra, M. T., Rodman, D. M., & Engelhardt, J. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7361-7366.2003 · Cited by 72
Arbetman, A. E., Lochrie, M. A., Zhou, S., Wellman, J. A., Scallan, C. D., Doroudchi, M. M., Randlev, B., Patarroyo-White, S. L., Liu, T., Smith, P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15238-15245.2005 · Cited by 72
Takeda, S., Takahashi, M., Mizukami, H., Kobayashi, E., Takeuchi, K., Hakamata, Y., Kaneko, T., Yamamoto, H., Ito, C., Ozawa, K., et al. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077378 · Cited by 68
Denby, L., Nicklin, S. A., & Baker, A. H. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302564 · Cited by 61
Identification and Characterization of Novel Adeno-Associated Virus Isolates in ATCC Virus Stocks
Schmidt, M., Grot, E., Cervenka, P. D., Wainer, S., Buck, C. D., & Chiorini, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5082-5085.2006 · Cited by 59
Physicochemical Characterization of Adeno-associated Satellite Virus Type 4 and Its Nucleic Acid
Parks, W. P., Green, M., Piña, M., & Melnick, J. L. (1967) · Journal of Virology · doi:10.1128/jvi.1.5.980-987.1967 · Cited by 58
Coinfection of a Bearded Dragon, Pogona vitticeps , with Adenovirus- and Dependovirus-like Viruses
Jacobson, E. R., Kopit, W., Kennedy, F. A., & Funk, R. S. (1996) · Veterinary Pathology · doi:10.1177/030098589603300313 · Cited by 53
DiMattia, M. A., Govindasamy, L., Levy, H. C., Gurda, B. L., Kalina, A., Kohlbrenner, E., Chiorini, J. A., McKENNA, R. V., Muzyczka, N., Zolotukhin, S., et al. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105028514 · Cited by 48
Zhang, H., Xie, J., Dmitriev, I. P., Kashentseva, E. A., Curiel, D. T., Hsu, H., & Mountz, J. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12023-12031.2002 · Cited by 44
Loiler, S., Tang, Q., Clarke, T., Campbell‐Thompson, M., Chiodo, V. A., Hauswirth, W. W., Cruz, P. E., Perret-Gentil, M., Atkinson, M. A., Ramiya, V. K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.017 · Cited by 40
Zhang, H.-G., Wang, Y., Xie, J., Liang, X., Hsu, H.-C., Zhang, X., Douglas, J. T., Curiel, D. T., & Mountz, J. D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301454 · Cited by 30
Lane, M. D., Nam, H.-J., Padron, E., Gurda, B. L., Kohlbrenner, E., Aslanidi, G., Byrne, B. J., McKENNA, R. V., Muzyczka, N., Zolotukhin, S., et al. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105014132 · Cited by 25
Isolation of an Adenovirus and an Adeno-Associated Virus from Goat Kids with Enteritis
Olson, E. J., Haskell, S. R. R., Frank, R. K., Lehmkuhl, H. D., Hobbs, L. A., Warg, J. V., Landgraf, J. G., & Wünschmann, A. (2004) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063870401600518 · Cited by 25
Dutta, S. K. (1975) · American Journal of Veterinary Research · doi:10.2460/ajvr.1975.36.03.247 · Cited by 25
Wustner, J., Arnold, S. G., Lock, M. W., Richardson, J. C., Himes, V. B., Kurtzman, G. J., & PELUSO, R. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0695 · Cited by 15
Research works printed but not linked: 1
- Zhou, 2005, Roles of inverted terminal repeats (ITRs) and capsid proteins from novel NHP AAVs in rAAV mediated gene transfer, Mol. Ther., 11, S156, 10.1016/j.ymthe.2005.06.407 · doi:10.1016/j.ymthe.2005.06.407
Cited by
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Self-citationStrategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061
Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., & Masurier, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.182 · Cited by 970
Metadata
- Authors
- Wu, Z., Asokan, A., & Samulski, R. J.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 14
- Issue
- 3
- Pages
- 316-327
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2046488302
- Cited by
- 922
- References
- 125
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 3689 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.